These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8392213)

  • 1. Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
    Besa PC; Hunter NR; Milas L
    Radiat Res; 1993 Jul; 135(1):93-7. PubMed ID: 8392213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole.
    Milas L; Ito H; Nakayama T; Hunter N
    Cancer Res; 1991 Jul; 51(14):3639-42. PubMed ID: 2065321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
    Grégoire V; Hunter NR; Brock WA; Hittelman WN; Plunkett W; Milas L
    Radiat Res; 1996 Nov; 146(5):548-53. PubMed ID: 8896581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in radioresponse of murine tumors by treatment with indomethacin.
    Furuta Y; Hunter N; Barkley T; Hall E; Milas L
    Cancer Res; 1988 Jun; 48(11):3008-13. PubMed ID: 3365690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice.
    Hunter N; Milas L
    Cancer Res; 1983 Apr; 43(4):1630-2. PubMed ID: 6831410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence.
    Milas L; Furuta Y; Hunter N; Nishiguchi I; Runkel S
    Cancer Res; 1990 Aug; 50(15):4473-7. PubMed ID: 2369725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.
    Milas L; Nishiguchi I; Hunter N; Murray D; Fleck R; Ito H; Travis E
    Adv Space Res; 1992; 12(2-3):265-71. PubMed ID: 11537017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioprotection of hematopoietic tissues in mice by indomethacin.
    Nishiguchi I; Furuta Y; Hunter N; Murray D; Milas L
    Radiat Res; 1990 May; 122(2):188-92. PubMed ID: 2159648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
    Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
    Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury.
    Hanson WR; Zhen W; Geng L; Hunter N; Milas L
    Radiat Res; 1995 Jun; 142(3):281-7. PubMed ID: 7761578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine.
    Prasanna PG; Uma Devi P
    Radiat Res; 1993 Jan; 133(1):111-5. PubMed ID: 8381976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK; Walden TL; Hughes HN; Jackson WE
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L; Hunter N; Stephens LC; Peters LJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis.
    Epperly MW; Carpenter M; Agarwal A; Mitra P; Nie S; Greenberger JS
    In Vivo; 2004; 18(4):401-10. PubMed ID: 15369176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors.
    Maisin JR; Albert C; Henry A
    Radiat Res; 1993 Sep; 135(3):332-7. PubMed ID: 8397428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimutagenic effects of amifostine: clinical implications.
    Kataoka Y; Perrin J; Hunter N; Milas L; Grdina DJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):53-7. PubMed ID: 8783668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG oligodeoxynucleotide enhances tumor response to radiation.
    Milas L; Mason KA; Ariga H; Hunter N; Neal R; Valdecanas D; Krieg AM; Whisnant JK
    Cancer Res; 2004 Aug; 64(15):5074-7. PubMed ID: 15289307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.